Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLendinvest Regulatory News (LINV)

Share Price Information for Lendinvest (LINV)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 29.00
Bid: 28.00
Ask: 30.00
Change: 0.00 (0.00%)
Spread: 2.00 (7.143%)
Open: 29.00
High: 29.00
Low: 29.00
Prev. Close: 29.00
LINV Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of AGM

8 Sep 2022 16:02

RNS Number : 8303Y
Lendinvest PLC
08 September 2022
 

LEI: 213800NWMK3O4UWP9N91

 

8 September 2022

LendInvest plc

("LendInvest" or the "Company")

 

Results of Annual General Meeting held on 8 September 2022

 

LendInvest plc (AIM: LINV), a leading technology driven asset manager for UK property finance, announces that, at its Annual General Meeting held earlier today, all of the resolutions as set out in the Notice of Annual General Meeting were approved by way of a show of hands.

 

As at 6 September 2022, the number of issued ordinary £0.0005 shares of the Company was 138,381,046. This represents the total number of shares entitling the holders to attend and vote for or against all resolutions. 116,556,783 proxy votes were received representing 84.23% of the issued share capital of LendInvest.

 

Details of the proxy votes received before the meeting on each resolution by Equiniti, LendInvest's Registrar, are set out below. Full text of all of the resolutions is set out in the Notice of Annual General Meeting, a copy of which is available on the Company's website.

 

 

 

Resolutions

Total votes

For

(%)

Against

(%)

Vote

Withheld1

1.

Ordinary resolution to receive the audited accounts for the financial year ended 31 March 2022, together with the directors' report and independent auditor's report on those accounts.

 

99,425,743

100.0%

 

0

0.0%

 

17,131,040

 

2.

Ordinary resolution to approve the Directors' remuneration report for the financial year ended 31 March 2022.

 

99,425,743

100.0%

 

0

0.0%

17,131,040

3.

Ordinary resolution to declare a final dividend of 4.4 pence per ordinary share in the capital of the Company ("Share") for the financial year ended 31 March 2022.

 

99,425,743

100.0%

0

0.0%

17,131,040

4.

Ordinary resolution to re-appoint BDO LLP as auditor of the Company, from the end of this annual general meeting until the end of the next general meeting of the Company at which accounts are laid.

 

99,425,743

100.0%

0

0.0%

17,131,040

5.

Ordinary resolution to authorise the Audit and Risk Committee of the Company (for and on behalf of the Board) to determine the auditors' remuneration.

 

99,425,743

100.0%

0

0.0%

17,131,040

6.

Ordinary resolution to authorise the Company and any company which is, or becomes, a subsidiary of the Company to make political donations and incur political expenditure not exceeding £50,000.

 

95,690,238

96.2%

 

 

3,735,505

3.8%

 

 

17,131,040

7.

Ordinary Resolution to authorise the directors to allot securities up to an aggregate nominal value of £46,127.

 

82,784,393

83.3%

 

16,641,350

16.7%

 

17,131,040

8.

Special resolution to give the directors power to allot securities for cash without making an offer to shareholders, generally, up to an aggregate nominal value of £3,459.

 

99,425,238

100.0%

 

505

0.0%

 

17,131,040

9.

Special resolution to give the directors power to allot securities for cash without making an offer to shareholders, in order to finance acquisitions, up to an aggregate nominal value of £3,459.

 

99,425,238

100.0%

 

505

0.0%

 

17,131,040

10.

Special resolution to give the Company limited authority to purchase up to 13,838,104 of its own shares.

 

99,425,743

100.0%

 

0

0.0%

 

17,131,040

 

1 A vote withheld is not a vote in law and is not counted in the calculation of the votes for or against a resolution.

 

 

For further information, please contact:

 

LendInvest via Tulchan Communications +44 (0)20 7353 4200

Rod Lockhart, Chief Executive Officer

Michael Evans, Chief Financial Officer

Alex Dee, Head of Investor Relations

Leigh Rimmer, Senior PR Manager

investorrelations@lendinvest.com

 

Panmure Gordon (NOMAD and Joint Broker) +44 (0)20 7886 2500

Atholl Tweedie

Charles Leigh-Pemberton

 

finnCap Limited (Joint Broker) +44 (0)20 7220 0500

Jonny Franklin-Adams/George Dollemore (Corporate Finance)

Tim Redfern/Alice Lane (ECM)

 

Tulchan Communications (Financial PR) +44 (0)20 7353 4200

Tom Murray

Matt Low

Misha Bayliss

Olivia Lucas

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGGZGGLKRGGZZM
12
Date   Source Headline
29th Jul 20223:14 pmRNSHolding(s) in Company
29th Jul 20223:12 pmRNSHolding(s) in Company
12th Jul 202212:38 pmRNSPublication of Base Prospectus
11th Jul 20224:48 pmRNSUpdate on EBT Purchase and Total Voting Rights
8th Jul 20229:11 amRNSDirector/PDMR Shareholding
6th Jul 20227:00 amRNSPublication of Annual Report
4th Jul 20229:30 amRNSRoadshow Announcement
4th Jul 20228:30 amRNSProposed purchase of shares in LendInvest plc
29th Jun 20227:00 amRNSLendInvest plc Full Year Financial Results FY22
14th Jun 202210:18 amRNSNotice of Results
6th Jun 20227:00 amRNSChange of Advisers
13th May 20223:17 pmRNSAnnouncement of Securitisation Settlement
29th Apr 20227:00 amRNSAnnouncement of Securitisation Transaction
8th Apr 20227:00 amRNSTrading Update
18th Feb 20227:00 amRNSNotice of Investor Webinar: Our Technology
11th Feb 20227:00 amRNSBlock Listing and Total Voting Rights
25th Jan 20227:00 amRNSAppointment of Independent Non-Executive Director
24th Jan 20227:00 amRNSLendInvest reaches £2 billion AuM milestone
13th Dec 202112:07 pmRNSHolding(s) in Company
9th Dec 20217:38 amRNSAppointment of Joint Broker
9th Dec 20217:00 amRNSInterim Financial Results
3rd Dec 20217:00 amRNSInvestor Presentation
5th Nov 20215:23 pmRNSNotification of share pledges
12th Oct 20217:00 amRNSInitiation of research coverage
11th Oct 20217:00 amRNSH1 Trading Update
5th Oct 20218:02 amRNSNotice of Trading Update
20th Sep 20215:44 pmRNSLoan Portfolio Sale
31st Aug 202112:16 pmRNSTotal Voting Rights
23rd Aug 20215:21 pmRNSDirector/PDMR Shareholding
9th Aug 20215:32 pmRNSApplication for block admission
27th Jul 202111:55 amRNSAudited Financial Statements (PLC)
14th Jul 20218:53 amRNSHolding(s) in Company
14th Jul 20218:47 amRNSHolding(s) in Company
14th Jul 20218:45 amRNSHolding(s) in Company
14th Jul 20218:00 amRNSAdmission to AIM and first day of dealings
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.